Literature DB >> 17056573

Characterization of the divergent wound-healing responses occurring in the pathergy reaction and normal healthy volunteers.

Melike Melikoglu1, Serpil Uysal, James G Krueger, Gilla Kaplan, Feride Gogus, Hasan Yazici, Stephen Oliver.   

Abstract

Behçet's disease (BD) is a multisystem inflammatory disorder of unknown etiology characterized by recurrent oral and genital ulcerations and uveitis, with varying other manifestations associated with vascular inflammation. A unifying feature of BD inflammation is the skin pathergy reaction (SPR), a nonspecific tissue hyperreactivity to minor trauma involving epithelial disruption. This study compared skin responses to needle prick in BD patients and normal healthy volunteers. Two study groups, each consisting of 10 BD patients with SPR(+) and 6 controls, were evaluated using either immunohistochemistry or quantitative real-time PCR to measure inflammatory cell and cytokine levels in biopsy specimens obtained serially from independent sites at 0, 8, and 48 h after needle prick. We found similar cellular infiltration patterns in response to needle prick in BD patients and controls between 0 and 8 h. Further development of this immune response was limited in skin of normal control subjects, with stable or decreased inflammatory mediators observed at 48 h. In contrast, in BD-derived skin specimens, increased influxes of mature dendritic cells, monocytes, and lymphocytes, including T regulatory cells, were noted by 48 h. Similarly, increases in cytokines (IFN-gamma, IL-12 p40, IL-15), chemokines (MIP3-alpha, IP-10, Mig, and iTac), and adhesion molecules (ICAM-1, VCAM-1) were noted at 48 h in the skin of BD patients with SPR(+) but not in the skin of normal controls. These results suggest that, in contrast to the self-limited inflammation associated with epithelial disruption of normal skin, BD patients experience marked cellular influxes into the injury site, leading to an exaggerated lymphoid Th1-type response.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17056573     DOI: 10.4049/jimmunol.177.9.6415

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  20 in total

Review 1.  Innate immune cells in the pathogenesis of primary systemic vasculitis.

Authors:  Durga Prasanna Misra; Vikas Agarwal
Journal:  Rheumatol Int       Date:  2015-09-24       Impact factor: 2.631

2.  Involvement of innate immunity in the pathogenesis of intestinal Behçet's disease.

Authors:  K Nara; M S Kurokawa; S Chiba; H Yoshikawa; S Tsukikawa; T Matsuda; N Suzuki
Journal:  Clin Exp Immunol       Date:  2008-03-10       Impact factor: 4.330

Review 3.  The unique features of vasculitis in Behçet's syndrome.

Authors:  Melike Melikoglu; Emire Kural-Seyahi; Koray Tascilar; Hasan Yazici
Journal:  Clin Rev Allergy Immunol       Date:  2008-10       Impact factor: 8.667

4.  Interleukin-15 and its receptor (IL-15Rα) serve as new therapeutic implications for Behçet's disease.

Authors:  Yong He; Cheng Huang; Bao-Ming Wu; Jun Li
Journal:  Rheumatol Int       Date:  2013-09-18       Impact factor: 2.631

5.  Possible association of proinflammatory cytokines including IL1β and TNFα with enhanced Th17 cell differentiation in patients with Behcet's disease.

Authors:  Jun Shimizu; Kenji Takai; Erika Takada; Naruyoshi Fujiwara; Nagisa Arimitsu; Yuji Ueda; Sueshige Wakisaka; Tomoko Suzuki; Noboru Suzuki
Journal:  Clin Rheumatol       Date:  2015-05-14       Impact factor: 2.980

6.  Excessive CD4+ T cells co-expressing interleukin-17 and interferon-γ in patients with Behçet's disease.

Authors:  J Shimizu; K Takai; N Fujiwara; N Arimitsu; Y Ueda; S Wakisaka; H Yoshikawa; F Kaneko; T Suzuki; N Suzuki
Journal:  Clin Exp Immunol       Date:  2012-04       Impact factor: 4.330

7.  Coronary involvement in patients with Behçet's disease.

Authors:  Hua Chen; Yuehua Zhang; Chaoran Li; Wei Wu; Jinjing Liu; Fengchun Zhang; Wenjie Zheng
Journal:  Clin Rheumatol       Date:  2019-06-28       Impact factor: 2.980

8.  T helper type 1-related molecules as well as interleukin-15 are hyperexpressed in the skin lesions of patients with pyoderma gangrenosum.

Authors:  E Antiga; R Maglie; W Volpi; B Bianchi; E Berti; A V Marzano; M Caproni
Journal:  Clin Exp Immunol       Date:  2017-06-23       Impact factor: 4.330

Review 9.  'MHC-I-opathy'-unified concept for spondyloarthritis and Behçet disease.

Authors:  Dennis McGonagle; Sibel Zehra Aydin; Ahmet Gül; Alfred Mahr; Haner Direskeneli
Journal:  Nat Rev Rheumatol       Date:  2015-11-03       Impact factor: 20.543

10.  Do synovial biopsies help to support evidence for involvement of innate immunity in the immunopathology of Behçet's disease?

Authors:  Jan A M van Laar; Jasper H Kappen; Paul L A van Daele; P Martin van Hagen
Journal:  Arthritis Res Ther       Date:  2009-04-30       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.